Modulation of hepatic stellate cells and reversibility of hepatic fibrosis

Exp Cell Res. 2017 Mar 15;352(2):420-426. doi: 10.1016/j.yexcr.2017.02.038. Epub 2017 Feb 24.

Abstract

Hepatic fibrosis (HF) is the pathological component of a variety of chronic liver diseases. Hepatic stellate cells (HSC) are the main collagen-producing cells in the liver and their activation promotes HF. If HSC activation and proliferation can be inhibited, HF occurrence and development can theoretically be reduced and even reversed. Over the past ten years, a number of studies have addressed this process, and here we present a review of HSC modulation and HF reversal.

Keywords: Hepatic fibrosis; Hepatic stellate cells; Mechanism; Modulation; Reversibility.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Hepatic Stellate Cells / metabolism*
  • Hepatic Stellate Cells / pathology
  • Humans
  • Immunity, Innate
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use
  • Liver Cirrhosis / drug therapy
  • Liver Cirrhosis / immunology*
  • Liver Cirrhosis / pathology

Substances

  • Immunologic Factors